Literature DB >> 27186416

Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression.

Si Shi1, Qicheng Zhang1, Yunfei Xia2, Bo You1, Ying Shan1, Lili Bao1, Li Li1, Yiwen You1, Zhifeng Gu2.   

Abstract

Mesenchymal stem cells (MSCs), which are capable of differentiating into multiple cell types, are reported to exert multiple effects on tumor development. However, the relationship between MSCs and nasopharyngeal carcinoma (NPC) cells remains unclear. Exosomes are small membrane vesicles that can be released by several cell types, including MSCs. Exosomes, which can carry membrane and cytoplasmic constituents, have been described as participants in a novel mechanism of cell-to-cell communication. In the present study, we investigated the mechanisms underlying the interaction between MSCs and NPC cells. The data showed that MSCs secreted 40-100 nm heterogeneous small vesicles, which were defined as exosomes. Incubation of NPC cells with MSC-derived exosomes resulted in the uptake of exosomes by the cells, which promoted their proliferation, migration and tumorigenesis. After an extended treatment duration, the tumor cells showed morphological changes and significant changes in the expression of epithelial-mesenchymal transition (EMT) markers. Moreover, we found that FGF19 was highly expressed in MSC-exosomes and that exosomes stimulated NPC progression by activating the FGF19-FGFR4-dependent ERK signaling cascade and by modulating the EMT. All of these data indicated that exosomes participate in a novel mechanism by which MSCs influence NPC progression.

Entities:  

Keywords:  FGF19/FGFR4 signaling; Mesenchymal stem cells (MSCs); epithelial-mesenchymal transition (EMT); exosomes; metastasis; nasopharyngeal carcinoma (NPC)

Year:  2016        PMID: 27186416      PMCID: PMC4859673     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  42 in total

1.  Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.

Authors:  Astrid De Boeck; Patrick Pauwels; Karen Hensen; Jean-Luc Rummens; Wendy Westbroek; An Hendrix; Dawn Maynard; Hannelore Denys; Kathleen Lambein; Geert Braems; Christian Gespach; Marc Bracke; Olivier De Wever
Journal:  Gut       Date:  2012-04-25       Impact factor: 23.059

Review 2.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

3.  Mesenchymal stem cells enhance growth and metastasis of colon cancer.

Authors:  Kei Shinagawa; Yasuhiko Kitadai; Miwako Tanaka; Tomonori Sumida; Michiyo Kodama; Yukihito Higashi; Shinji Tanaka; Wataru Yasui; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

4.  Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.

Authors:  Zhifeng Gu; Xiaolei Cao; Jinxia Jiang; Liren Li; Zhanyun Da; Hong Liu; Chun Cheng
Journal:  Cell Signal       Date:  2012-07-20       Impact factor: 4.315

5.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

Authors:  Michael Quante; Shui Ping Tu; Hiroyuki Tomita; Tamas Gonda; Sophie S W Wang; Shigeo Takashi; Gwang Ho Baik; Wataru Shibata; Bethany Diprete; Kelly S Betz; Richard Friedman; Andrea Varro; Benjamin Tycko; Timothy C Wang
Journal:  Cancer Cell       Date:  2011-02-15       Impact factor: 31.743

6.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

8.  Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.

Authors:  Mong-Lien Wang; Chih-Ming Pan; Shih-Hwa Chiou; Wen-Hsin Chen; Hsiang-Yi Chang; Oscar Kuang-Sheng Lee; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2012-11-08       Impact factor: 12.701

9.  Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma.

Authors:  Shannon Kidd; Erika Spaeth; Keri Watson; Jared Burks; Hongbo Lu; Ann Klopp; Michael Andreeff; Frank C Marini
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

Review 10.  Exosomes derived from mesenchymal stem cells.

Authors:  Bo Yu; Xiaomin Zhang; Xiaorong Li
Journal:  Int J Mol Sci       Date:  2014-03-07       Impact factor: 5.923

View more
  31 in total

Review 1.  Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.

Authors:  Theresa L Whiteside
Journal:  Semin Immunol       Date:  2017-12-27       Impact factor: 11.130

Review 2.  The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Authors:  Vignesh Sundararajan; Fazlul H Sarkar; Thamil Selvee Ramasamy
Journal:  Cell Oncol (Dordr)       Date:  2018-04-17       Impact factor: 6.730

Review 3.  Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.

Authors:  Marcelo Coutinho de Miranda; Mariane Izabella Abreu de Melo; Pricila da Silva Cunha; Jovino Gentilini; Jerusa Araújo Quintão Arantes Faria; Michele Angela Rodrigues; Dawidson Assis Gomes
Journal:  Biomed Pharmacother       Date:  2021-11-05       Impact factor: 6.529

Review 4.  Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.

Authors:  Gati Krushna Panigrahi; Gagan Deep
Journal:  Front Biosci (Landmark Ed)       Date:  2017-06-01

Review 5.  Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.

Authors:  Alessandro Poggi; Massimo Giuliani
Journal:  Vaccines (Basel)       Date:  2016-11-08

Review 6.  Interaction of MSC with tumor cells.

Authors:  Catharina Melzer; Yuanyuan Yang; Ralf Hass
Journal:  Cell Commun Signal       Date:  2016-09-08       Impact factor: 5.712

Review 7.  How Do Mesenchymal Stem Cells Influence or Are Influenced by Microenvironment through Extracellular Vesicles Communication?

Authors:  Gabriel Dostert; Benjamin Mesure; Patrick Menu; Émilie Velot
Journal:  Front Cell Dev Biol       Date:  2017-02-07

Review 8.  Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases.

Authors:  Guohua Lou; Zhi Chen; Min Zheng; Yanning Liu
Journal:  Exp Mol Med       Date:  2017-06-16       Impact factor: 8.718

Review 9.  Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.

Authors:  Daria S Chulpanova; Kristina V Kitaeva; Leysan G Tazetdinova; Victoria James; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

Review 10.  The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application.

Authors:  Huidan Luo; Bin Yi
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.